These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 6243330)

  • 1. Elicitation of anti-Sendai virus cytotoxic T lymphocytes by viral and H-2 antigens incorporated into the same lipid bilayer by membrane fusion and by reconstitution into liposomes.
    Hale AH; Lyles DS; Fan DP
    J Immunol; 1980 Feb; 124(2):724-31. PubMed ID: 6243330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elicitation of anti-viral cytotoxic T lymphocytes with purified viral and H-2 antigens.
    Hale AH; Ruebush MJ; Harris DT
    J Immunol; 1980 Jul; 125(1):428-30. PubMed ID: 6247399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elicitation of primary anti-Sendai virus cytotoxic T lymphocytes with purified viral glycoproteins.
    McGee M; Hale AH; Panetti M
    Eur J Immunol; 1980 Dec; 10(12):923-8. PubMed ID: 6258925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal molecular requirements for reactivity of tumor cells with T cells.
    Hale AH; Lyles DS; Paulus LK; Ruebush MJ
    J Immunol; 1980 May; 124(5):2063-70. PubMed ID: 6245133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of virus specific cytotoxic T cells in vitro. III. Spleen cells stimulated by viral antigens generate alloreactive cytotoxic T cells.
    Koszinowski U; Greber D; Neuschaefer-Rube I
    Immunobiology; 1979 Aug; 156(1-2):83-95. PubMed ID: 232074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elicitation of anti-H-2 cytotoxic T lymphocytes with antigen-modified H-2 negative stimulator cells.
    Hale AH; Ruebush MJ; Harris DT; McGee MP
    J Immunol; 1981 Apr; 126(4):1485-8. PubMed ID: 6970778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-liposome modification of target cells as a method to alter their susceptibility to lysis by cytotoxic T lymphocytes.
    Hale AH; Ruebush MJ; Lyles DS; Harris DT
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6105-8. PubMed ID: 6255476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ; Wheelock EF
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immunity to herpes simplex virus: induction of cytotoxic T lymphocyte responses by viral antigens incorporated into liposomes.
    Lawman MJ; Naylor PT; Huang L; Courtney RJ; Rouse BT
    J Immunol; 1981 Jan; 126(1):304-8. PubMed ID: 6969745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of virus-specific cytotoxic T cells in vitro. I. Induction conditions of primary and secondary Sendai virus-specific cytotoxic T cells.
    Koszinowski UH; Simon MM
    Eur J Immunol; 1979 Sep; 9(9):715-22. PubMed ID: 92413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary in vitro sensitization of virus specific cytotoxic T lymphocytes.
    Jung H; Pfizenmaier K; Starzinski-Powitz A; Röllinghoff M; Wagner H
    Immunology; 1978 Apr; 34(4):763-9. PubMed ID: 82534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ir gene control of the cytotoxic T lymphocyte response to Sendai virus: H-2k mice are low responders to Sendai.
    Shapiro ME; Burakoff SJ; Benacerraf B; Finberg RW
    J Immunol; 1981 Dec; 127(6):2571-4. PubMed ID: 6271873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the cytotoxic T lymphocyte response against Sendai virus analyzed with H-2 mutants.
    de Waal LP; Kast WM; Melvold RW; Melief CJ
    J Immunol; 1983 Mar; 130(3):1090-6. PubMed ID: 6185570
    [No Abstract]   [Full Text] [Related]  

  • 14. H-2-linked murine cytotoxic T cell responses specific for sendai virus-infected cells.
    Kurrle R; Röllinghoff M; Wagner H
    Eur J Immunol; 1978 Dec; 8(12):910-2. PubMed ID: 83237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of virus-specific cytotoxic T cells in vitro. II. Induction requirements with functionally inactivated virus preparations.
    Koszinowski UH; Gething MJ
    Eur J Immunol; 1980 Jan; 10(1):30-5. PubMed ID: 6244963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of H-2-specific antibodies by injections of syngeneic Sendai virus-coated cells.
    Kievits F; Rocca A; Opolski A; Limpens J; Leupers T; Kloosterman T; Boerenkamp WJ; Pla M; Ivanyi P
    Eur J Immunol; 1987 Jan; 17(1):27-35. PubMed ID: 3028822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms for generating cell membrane antigens that are recognized by cytotoxic T lymphocytes.
    Ciavarra R; Kang CY; Forman J
    Fed Proc; 1981 Feb; 40(2):222-7. PubMed ID: 6257559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysis of target cells infected with vesicular stomatitis virus (VSV) in the presence of tunicamycin by anti-VSV cytotoxic T lymphocytes.
    Harris DT; Hale AH; Lefrancois L
    J Immunol; 1981 May; 126(5):1914-8. PubMed ID: 6260860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient priming of CD8+ memory T cells specific for a subdominant epitope following Sendai virus infection.
    Cole GA; Hogg TL; Coppola MA; Woodland DL
    J Immunol; 1997 May; 158(9):4301-9. PubMed ID: 9126992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.